Cargando…
Opportunities for Antigen Discovery in Metastatic Breast Cancer
Immune checkpoint inhibitor-based immunotherapy (ICI) of breast cancer is currently efficacious in a fraction of triple negative breast cancers (TNBC) as these cancers generally carry high tumor mutation burden (TMB) and show increased tumor infiltration by CD8(+) T cells. However, most estrogen rec...
Autores principales: | Sood, Ashwani K., Nemeth, Michael, Wang, Jianmin, Wu, Yun, Gandhi, Shipra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661635/ https://www.ncbi.nlm.nih.gov/pubmed/33193348 http://dx.doi.org/10.3389/fimmu.2020.570049 |
Ejemplares similares
-
Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic Hormone Receptor–Positive Breast Cancer
por: Sarma, Maithreyi, et al.
Publicado: (2020) -
Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities
por: Serr, Isabelle, et al.
Publicado: (2021) -
Massively-multiplexed epitope mapping techniques for viral antigen discovery
por: Hu, Diya, et al.
Publicado: (2023) -
Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
por: Chen, Long, et al.
Publicado: (2022) -
Antibodies Against Conserved Antigens Provide Opportunities for Reform in Influenza Vaccine Design
por: Kaminski, Denise A., et al.
Publicado: (2011)